Skip to main content
Gut and Liver logoLink to Gut and Liver
. 2020 Oct 8;15(1):146–147. doi: 10.5009/gnl15011

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Jung Rock Moon 1, Chang Kyun Lee 1, Sung Noh Hong 2, Jong Pil Im 3, Byong Duk Ye 4, Jae Myung Cha 5, Sung-Ae Jung 6, Kang-Moon Lee 7, Dong Il Park 8, Yoon Tae Jeen 9, Young Sook Park 10, Jae Hee Cheon 11, Hyesung Kim 12, BoJeong Seo 12, Youngdoe Kim 12, Hyo Jong Kim 1; the MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID)
PMCID: PMC7817936  PMID: 33443236

https://doi.org/10.5009/gnl19107

Gut Liver 2020;14(4):459-467

In the version of this article initially published, Table 2 contains an error in the data of p-value.

Table 2.

Mean Values of Each Patient-Reported Outcome Measure

PROs Category No. Overall (n=355) Disease severity p-value

Moderate (n=330)* Severe (n=25)
HADS Depression 349 6.6±4.5 6.5±4.4 8.9±5.2 0.610
Anxiety 348 6.2±4.4 6.2±4.4 6.6±4.5 0.638
WPAI:UC Absenteeism 149 29.1±36.9 27.3±35.8 54.1±43.5 0.102
Presenteeism§ 143 37.8±31.4 36.8±30.3 62.2±39.6 0.037
Overall work impairmentII 130 45.5±32.7 44.1±31.9 70.7±37.8 0.048
Social activity impairment 344 46.4±31.2 45.2±31.0 61.2±31.0 0.014
IBDQ Bowel system 344 41.7±13.0 42.0±13.1 36.1±10.9 0.027
Emotional health 347 51.7±14.9 52.0±14.9 46.8±13.6 0.097
Systemic symptoms 347 20.5±6.8 20.7±6.8 17.0±6.0 0.009
Social function 309 23.2±7.7 22.8±7.9 18.0±6.8 0.003
Total score 305 137.3±38.8 137.5±39.0 117.9±33.2 0.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.

On page 462, the table should be corrected as follows (marked in bold):

From:

To:

Table 2.

Mean Values of Each Patient-Reported Outcome Measure

PROs Category No. Overall (n=355) Disease severity p-value

Moderate (n=330)* Severe (n=25)
HADS Depression 349 6.6±4.5 6.5±4.4 8.9±5.2 0.024
Anxiety 348 6.2±4.4 6.2±4.4 6.6±4.5 0.638
WPAI:UC Absenteeism 149 29.1±36.9 27.3±35.8 54.1±43.5 0.102
Presenteeism§ 143 37.8±31.4 36.8±30.3 62.2±39.6 0.037
Overall work impairmentII 130 45.5±32.7 44.1±31.9 70.7±37.8 0.048
Social activity impairment 344 46.4±31.2 45.2±31.0 61.2±31.0 0.014
IBDQ Bowel system 344 41.7±13.0 42.0±13.1 36.1±10.9 0.027
Emotional health 347 51.7±14.9 52.0±14.9 46.8±13.6 0.097
Systemic symptoms 347 20.5±6.8 20.7±6.8 17.0±6.0 0.009
Social function 309 23.2±7.7 22.8±7.9 18.0±6.8 0.003
Total score 305 137.3±38.8 137.5±39.0 117.9±33.2 0.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.


Articles from Gut and Liver are provided here courtesy of The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association for the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, the Korean Society of Pancreatobiliary Disease, and the Korean Society of Gastrointestinal Cancer

RESOURCES